UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
August 3, 2017
Accession Number:
0001144204-17-039309
Submission Type:
POS AM
CIK:
0001425205
Company Name:
IOVANCE BIOTHERAPEUTICS, INC.
File Number:
333-214073